EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
獨家報道:Pasithea Treateutics宣佈臨牀前研究結果表明,耐受疫苗對復發-緩解型多發性硬化症有效
EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
獨家報道:Pasithea Treateutics宣佈臨牀前研究結果表明,耐受疫苗對復發-緩解型多發性硬化症有效